Ogan D. Abaan
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 1
-
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Jeffrey A. Toretsky (6 shared papers)Aykut Üren (5 shared papers)Paul S. Meltzer (5 shared papers)Sean R. Davis (4 shared papers)Robert L. Walker (3 shared papers)Marbin A. Pineda (2 shared papers)Hayriye Verda Erkizan (2 shared papers)Melinda S. Merchant (1 shared paper)
- Journals
- Nature Biotechnology (2 papers)Cancer Research (2 papers)Oncogene (2 papers)Nature Medicine (1 paper)Cancer and Metastasis Reviews (1 paper)
- Partner nations
- United StatesBrazilTürkiye
In The Last Decade
Ogan D. Abaan
16 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 74
- Cancer Research 197
- Genetics 118
- Pulmonary and Respiratory Medicine 393
- Molecular Biology 563
- Pathology and Forensic Medicine 120
Countries citing papers authored by Ogan D. Abaan
This map shows the geographic impact of Ogan D. Abaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ogan D. Abaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ogan D. Abaan more than expected).
Fields of papers citing papers by Ogan D. Abaan
This network shows the impact of papers produced by Ogan D. Abaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ogan D. Abaan. The network helps show where Ogan D. Abaan may publish in the future.
Co-authors
The 25 scholars most cited alongside Ogan D. Abaan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 373 | |
| 2 | 2013 | 226 | |
| 3 | 2013 | 217 | |
| 4 | 2009 | 144 | |
| 5 | 2021 | 113 | |
| 6 | 2006 | 110 | |
| 7 | 2021 | 67 | |
| 8 | 2005 | 62 | |
| 9 | 2008 | 56 | |
| 10 | 2014 | 35 | |
| 11 | 2013 | 30 | |
| 12 | 2015 | 29 | |
| 13 | 2011 | 20 | |
| 14 | 2009 | 16 | |
| 15 | 2012 | 11 | |
| 16 | Gene Therapy in Human Breast Cancer | 2002 | 8 |
About Ogan D. Abaan
Ogan D. Abaan is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Genetics and Oncology, having authored 16 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Protein Tyrosine Phosphatases (2 papers), Hedgehog Signaling Pathway Studies (1 paper), Cancer therapeutics and mechanisms (1 paper), Virus-based gene therapy research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (197 citations), Genetics (118 citations), Pulmonary and Respiratory Medicine (393 citations), Molecular Biology (563 citations) and Pathology and Forensic Medicine (120 citations). Ogan D. Abaan has collaborated with scholars based in United States, Brazil and Türkiye. Frequent co-authors include Jeffrey A. Toretsky, Aykut Üren, Paul S. Meltzer, Sean R. Davis, Robert L. Walker, Marbin A. Pineda, Hayriye Verda Erkizan, Melinda S. Merchant, Milton L. Brown and Silke Schlottmann. Their work appears in journals such as Nature Biotechnology, Cancer Research, Oncogene, Nature Medicine and Cancer and Metastasis Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.